The American Cancer Society for Oncology (ASCO) annual meeting is among the highlights of the clinical oncology calendar. The meeting...
Read more
At HotSpot, we are committed to building something we believe is truly distinctive, setting ourselves apart from our peers in...
Read more
Every company has a culture, either by design or default. From our inception in 2016, we wanted to create a...
Read more
The phrase ‘build it and they will come’ dates all the way back to the Old Testament, and in more...
Read more
HotSpot Therapeutics recently announced FDA clearance of our Investigational New Drug (IND) application for HST-1011, our small molecule allosteric inhibitor...
Read more